Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.70 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.52 |
| ▸ | AHCY | P23526 | 3/20 | 0.50 |
| ▸ | ADK | P55263 | 3/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.50 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.50 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.50 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.50 |
| ▸ | GAPDH | P04406 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | STAT6 | P42226 | 1/20 | 0.50 |
| ▸ | PI4KA | P42356 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.50 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8327434 | 1.00 | ADORA3 (0.70) | ADORA3SLC29A1AHCYADKADORA2A | |
| SCHEMBL6674140 | 0.99 | ADORA3 (0.69) | ADORA3SLC29A1AHCYADKADORA2A | |
| SCHEMBL2049339 | 0.86 | ADORA3 (0.70) | ADORA3SLC29A1AHCYADKADORA2A | |
| SCHEMBL2050691 | 0.86 | ADORA3 (0.70) | ADORA3SLC29A1AHCYADKADORA2A | |
| SCHEMBL2049342 | 0.86 | ADORA3 (0.70) | ADORA3SLC29A1AHCYADKADORA2A | |
| 5'-Deoxyadenosine SCHEMBL12453581 | 0.85 | AHCY (0.69) | ADORA3SLC29A1AHCYADORA2AADORA2B | |
| 5'-Deoxyadenosine SCHEMBL542617 | 0.85 | AHCY (0.69) | ADORA3SLC29A1AHCYADORA2AADORA2B | |
| 5'-Deoxyadenosine SCHEMBL3459552 | 0.85 | AHCY (0.69) | ADORA3SLC29A1AHCYADORA2AADORA2B | |
| SCHEMBL14264197 | 0.85 | ADORA3 (0.69) | ADORA3SLC29A1AHCYADKADORA2A | |
| 5'-Deoxyadenosine SCHEMBL17677150 | 0.85 | AHCY (0.69) | ADORA3SLC29A1AHCYADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331343-B2 | FAMIN assay methods | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-17 | — | — | US | claimed |
| EP-3894580-B1 | FAMIN ASSAY METHODS | CAMBRIDGE ENTPR LTD (GB) | 2024-04-24 | — | — | EP | claimed |
| US-20230220443-A1 | CHARACTERIZATION OF S-ADENOSYL-L-METHIONINE-CONSUMING ENZYMES WITH 1-STEP EZ-MTASE: A UNIVERSAL COUPLED-ASSAY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-13 | — | — | US | claimed |
| US-20220017943-A1 | FAMIN Assay Methods | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2022-01-20 | — | — | US | claimed |
| EP-3894580-A1 | FAMIN ASSAY METHODS | Cambridge Enterprise Limited (GB) | 2021-10-20 | — | — | EP | claimed |
| WO-2020120406-A1 | FAMIN ASSAY METHODS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2020-06-18 | — | — | WO | claimed |
| WO-2018156464-A1 | CHARACTERIZATION OF S-ADENOSYL-L-METHIONINE-CONSUMING ENZYMES WITH 1-STEP EZ-MTASE: A UNIVERSAL COUPLED-ASSAY | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2018-08-30 | — | — | WO | claimed |
| US-12331343-B2 | FAMIN assay methods | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-17 | — | — | US | disclosed |
| EP-3894580-B1 | FAMIN ASSAY METHODS | CAMBRIDGE ENTPR LTD (GB) | 2024-04-24 | — | — | EP | disclosed |
| US-20240124511-A1 | COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 | TIANJIN HONGKE BAISHI QIXIN VENTURE CAPITAL PARTNERSHIP (LIMITED PARTNERSHIP) (CN) | 2024-04-18 | — | — | US | disclosed |
| US-20240026421-A1 | METHODS FOR CAPTURING LONG POLYNUCLEOTIDES FOR SEQUENCING SPECIFIC GENOMIC REGIONS | GENERATION BIOTECH, LLC (US) | 2024-01-25 | — | — | US | disclosed |
| US-11840551-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) | 2023-12-12 | — | — | US | disclosed |
| US-11773131-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | SHANGHAI YAO YUAN BIOTECHNOLOGY CO., LTD. (CN) | 2023-10-03 | — | — | US | disclosed |
| EP-0682519-A4 | ADENOSINE KINASE INHIBITORS. | GENSIA INC (US) | 1997-12-17 | — | — | EP | disclosed |
| US-5646128-A | TREATING INFLAMMATION, SEPSIS, SEPTIC SHOCK, BURNS | GENSIA, INC. (US) | 1997-07-08 | — | — | US | disclosed |
| EP-0682519-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1994017803-A9 | ADENOSINE KINASE INHIBITORS | — | 1994-09-29 | — | — | WO | disclosed |
| WO-1994017803-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1994-08-18 | — | — | WO | disclosed |
| WO-1992012718-A1 | ADENOSINE KINASE INHIBITORS | GENSIA, INC. (US) | 1992-08-06 | — | — | WO | disclosed |
| EP-0496617-A1 | Adenosine kinase inhibitors | GENSIA, INC. (US) | 1992-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840551-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | PHKA1, PHKA2, PRKCA | ADORA3 739/4885SLC29A1 4529/4885AHCY 3099/4885 |
| US-20240124511-A1 | COMPOSITIONS AND METHODS OF MODULATING THE IMMUNE RESPONSE BY ACTIVATING ALPHA PROTEIN KINASE 1 | PHKA1, PHKA2, PRKCA | ADORA3 739/4885SLC29A1 4529/4885AHCY 3099/4885 |
| US-11773131-B2 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | PHKA1, PHKA2, PRKCA | ADORA3 739/4885SLC29A1 4529/4885AHCY 3099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.